JP2025160251A5 - - Google Patents

Info

Publication number
JP2025160251A5
JP2025160251A5 JP2025118767A JP2025118767A JP2025160251A5 JP 2025160251 A5 JP2025160251 A5 JP 2025160251A5 JP 2025118767 A JP2025118767 A JP 2025118767A JP 2025118767 A JP2025118767 A JP 2025118767A JP 2025160251 A5 JP2025160251 A5 JP 2025160251A5
Authority
JP
Japan
Prior art keywords
group
oxetanyl
cyclobutyl
optionally substituted
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025118767A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025160251A (ja
Filing date
Publication date
Priority claimed from JP2024540933A external-priority patent/JP7714811B2/ja
Application filed filed Critical
Publication of JP2025160251A publication Critical patent/JP2025160251A/ja
Publication of JP2025160251A5 publication Critical patent/JP2025160251A5/ja
Pending legal-status Critical Current

Links

JP2025118767A 2022-01-21 2025-07-15 1,3,4,7-テトラヒドロ-2H-ピロロ[3’,2’:5,6]ピリド[2,3-B][1,4]オキサアゼピンBcl-2阻害剤 Pending JP2025160251A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263267018P 2022-01-21 2022-01-21
US63/267,018 2022-01-21
JP2024540933A JP7714811B2 (ja) 2022-01-21 2023-01-20 1,3,4,7-テトラヒドロ-2H-ピロロ[3’,2’:5,6]ピリド[2,3-B][1,4]オキサアゼピンBcl-2阻害剤
PCT/US2023/060944 WO2023141536A1 (en) 2022-01-21 2023-01-20 1,3,4,7-tetrahydro-2h-pyrrolo [3',2':5,6] pyrido[2,3-b] [1,4] oxazepine bc1-2 inhibitors

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2024540933A Division JP7714811B2 (ja) 2022-01-21 2023-01-20 1,3,4,7-テトラヒドロ-2H-ピロロ[3’,2’:5,6]ピリド[2,3-B][1,4]オキサアゼピンBcl-2阻害剤

Publications (2)

Publication Number Publication Date
JP2025160251A JP2025160251A (ja) 2025-10-22
JP2025160251A5 true JP2025160251A5 (https=) 2026-01-27

Family

ID=85382827

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024540933A Active JP7714811B2 (ja) 2022-01-21 2023-01-20 1,3,4,7-テトラヒドロ-2H-ピロロ[3’,2’:5,6]ピリド[2,3-B][1,4]オキサアゼピンBcl-2阻害剤
JP2025118767A Pending JP2025160251A (ja) 2022-01-21 2025-07-15 1,3,4,7-テトラヒドロ-2H-ピロロ[3’,2’:5,6]ピリド[2,3-B][1,4]オキサアゼピンBcl-2阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2024540933A Active JP7714811B2 (ja) 2022-01-21 2023-01-20 1,3,4,7-テトラヒドロ-2H-ピロロ[3’,2’:5,6]ピリド[2,3-B][1,4]オキサアゼピンBcl-2阻害剤

Country Status (13)

Country Link
US (3) US11964990B2 (https=)
EP (1) EP4466273A1 (https=)
JP (2) JP7714811B2 (https=)
KR (1) KR20240136972A (https=)
CN (1) CN119053610A (https=)
AR (1) AR128310A1 (https=)
AU (1) AU2023210279A1 (https=)
CA (1) CA3242074A1 (https=)
CO (1) CO2024009334A2 (https=)
IL (1) IL312709A (https=)
MX (1) MX2024008840A (https=)
TW (1) TW202340210A (https=)
WO (1) WO2023141536A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11964990B2 (en) * 2022-01-21 2024-04-23 Abbvie Inc. 1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
CN117820134A (zh) * 2024-01-10 2024-04-05 山东盛安贝新材料有限公司南京分公司 一种顺式-3-甲氧基环丁胺盐酸盐的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018322059C1 (en) 2017-08-23 2024-09-12 Guangzhou Lupeng Pharmaceutical Company Ltd. BCL-2 inhibitors
US12220419B2 (en) 2018-08-22 2025-02-11 Newave Pharmaceutical Inc. BCL-2 inhibitors
WO2020140005A2 (en) 2018-12-29 2020-07-02 Newave Pharmaceutical Inc. Bcl-2 inhibitors
WO2021066873A1 (en) 2019-10-03 2021-04-08 Newave Pharmaceutical Inc. Condensed heterocycles as bcl-2 inhibitors
WO2021083135A1 (en) 2019-10-28 2021-05-06 Beigene, Ltd. Bcl-2 INHIBITORS
WO2021133817A1 (en) 2019-12-27 2021-07-01 Guangzhou Lupeng Pharmaceutical Company Ltd. 1h-pyrrolo[2,3-b]pyridine derivatives as bcl-2 inhibitors for the treatment of neoplastic and autoimmune diseases
KR20220158725A (ko) 2020-02-24 2022-12-01 광조우 루펭 파마슈티칼 컴퍼니 엘티디. Bcl2 억제제를 함유하는 핫 멜트 압출 고체 분산체
US11964990B2 (en) * 2022-01-21 2024-04-23 Abbvie Inc. 1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors

Similar Documents

Publication Publication Date Title
JP2025160251A5 (https=)
JP2024071370A5 (https=)
JPWO2023060253A5 (https=)
RU2011137457A (ru) Пестицыдные композиции
JP2007508359A5 (https=)
RU2009115653A (ru) Производные 5-замещенного хиназолинона, содержащие их композиции и способы их применения
JP2009526868A5 (https=)
JP2017504631A5 (https=)
AR035611A1 (es) 2 -azetidinonas sustituidas con azucares, composicion farmaceutica, un kit, uso de dichos compuestos para la fabricacion de medicamentos utiles como agentes hipocolesterolemicos.
RU2005114010A (ru) Производные азаиндола в качестве ингибиторов киназы р38
RU2008143457A (ru) Производные-2-пиразинона для лечения заболевания или состояния, при которых полезно ингибирование активности нейтрофильной эластазы
JP2004525117A5 (https=)
JP2006524222A5 (https=)
JP2011525192A5 (https=)
JP2009532417A5 (https=)
JP2006520397A5 (https=)
JPWO2020123827A5 (https=)
RU2010119487A (ru) Пиримидилиндолиновое соединение
JP2007519721A5 (https=)
JP2008516968A5 (https=)
JP2004530691A5 (https=)
JP2007502817A5 (https=)
CA2518224A1 (en) Novel isothiazolopyrimidinones and isoxazolopyrimidinones and uses thereof
AR048808A1 (es) Pirrolocarbazoles fusionados
JP2006523241A5 (https=)